| − | '''Medical marijuana''' is [[marijuana]] used for its analgesic or otherwise therapeutic effects (see [[Glaucoma]], [[Cancer]],<ref>{{Cite journal|author=Casanova ML, Blázquez C, Martínez-Palacio J, ''et al.'' |title=Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |journal=The Journal of Clinical Investigation |volume=111 |issue=1 |pages=43–50 |year=2003 |month=January |pmid=12511587 |pmc=151833 |doi=10.1172/JCI16116 |issn=0021-9738 |format=Free full text}}</ref><ref>{{Cite journal|author=Patsos HA, Hicks DJ, Dobson RR, ''et al.'' |title=The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 |journal=Gut |volume=54 |issue=12 |pages=1741–50 |year=2005 |month=December |pmid=16099783 |pmc=1774787 |doi=10.1136/gut.2005.073403 |issn=0017-5749}}</ref><ref>{{Cite journal|author=Lorente M, Carracedo A, Torres S, ''et al.'' |title=Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis |journal=Glia |volume= 57|issue= 13|pages=NA |year=2009 |month=February |pmid=19229996 |doi=10.1002/glia.20856 |issn=0894-1491}}</ref><ref>{{Cite journal|author=Ramer R, Hinz B |title=Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 |journal=Journal of the National Cancer Institute |volume=100 |issue=1 |pages=59–69 |year=2008 |month=January |pmid=18159069 |doi=10.1093/jnci/djm268 |issn=0027-8874 |url=http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18159069 |format=Free full text}}</ref><ref>{{Cite journal|author=Powles T, te Poele R, Shamash J, ''et al.'' |title=Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway |journal=Blood |volume=105 |issue=3 |pages=1214–21 |year=2005 |month=February |pmid=15454482 |doi=10.1182/blood-2004-03-1182 |issn=0006-4971 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=15454482 |format=Free full text}}</ref> [[Anorexia Nervosa]],<ref>Grotenhermen, Russo. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002,. Grotenhermen, “Review of Therapeutic Effects.” Chapter 11, p. 128</ref> [[Amyotrophic Lateral Sclerosis]],<ref>{{Cite journal|author=Carter GT, Rosen BS |title=Marijuana in the management of amyotrophic lateral sclerosis |journal=The American Journal of Hospice & Palliative Care |volume=18 |issue=4 |pages=264–70 |year=2001 |pmid=11467101 |doi=10.1177/104990910101800411 |month= July|issn=1049-9091}}</ref><ref>{{Cite journal|author=Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M |title=Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival |journal=Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders |volume=6 |issue=3 |pages=182–4 |year=2005 |month=September |pmid=16183560 |doi=10.1080/14660820510030149 |url=http://www.informaworld.com/smpp/content~db=all~content=a723777607 |issn=1466-0822}}</ref> [[Seizures]], [[Schizophrenia]],<ref>Zuardi A.W., Crippa J.A.S., Hallak J.E.C., Moreira F.A., Guimarães F.S. Brazilian Journal of Medical and Biological Research [http://www.scielo.br/pdf/bjmbr/v39n4/6164.pdf Cannabidiol as an antipsychotic drug] (PDF) 2006. Vol. 39. Page 421-9. ISSN 0100-879X</ref> [[tumor|Skin Tumors]],<ref>{{Cite journal|author=Casanova ML, Blázquez C, Martínez-Palacio J, ''et al.'' |title=Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |journal=The Journal of Clinical Investigation |volume=111 |issue=1 |pages=43–50 |year=2003 |month=January |pmid=12511587 |pmc=151833 |doi=10.1172/JCI16116 |issn=0021-9738 |format=Free full text}}</ref><ref>[http://www.sciencedaily.com/releases/2007/04/070417193338.htm Science Daily 4/7/2007]</ref> [[Gliomas]],<ref>{{Cite journal|author=Lorente M, Carracedo A, Torres S, ''et al.'' |title=Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis |journal=Glia |volume= 57|issue= 13|pages=NA |year=2009 |month=February |pmid=19229996 |doi=10.1002/glia.20856 |issn=0894-1491}}</ref><ref>{{Cite journal|author=Ramer R, Hinz B |title=Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 |journal=Journal of the National Cancer Institute |volume=100 |issue=1 |pages=59–69 |year=2008 |month=January |pmid=18159069 |doi=10.1093/jnci/djm268 |issn=0027-8874 |url=http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18159069 |format=Free full text}}</ref> [[Arthritis]],<ref>{{Cite journal|author=Malfait AM, Gallily R, Sumariwalla PF, ''et al.'' |title=The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis |journal=Proceedings of the National Academy of Sciences of the United States of America |volume=97 |issue=17 |pages=9561–6 |year=2000 |month=August |pmid=10920191 |pmc=16904 |doi=10.1073/pnas.160105897 |issn=0027-8424 |url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=10920191 |format=Free full text}}</ref> [[Bipolar Disorder]],<ref>{{Cite journal|author=Grinspoon L, Bakalar JB |title=The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research |journal=Journal of Psychoactive Drugs |volume=30 |issue=2 |pages=171–7 |year=1998 |pmid=9692379 |url=http://www.ukcia.org/research/TheUseofCannabisasaMoodStabilizerinBipolarDisorder.html |month= April|issn=0279-1072}}</ref><ref>{{Cite journal|author=Ashton CH, Moore PB, Gallagher P, Young AH |title=Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential |journal=Journal of Psychopharmacology |volume=19 |issue=3 |pages=293–300 |year=2005 |month=May |pmid=15888515 |doi=10.1177/0269881105051541 |issn=0269-8811}}</ref> [[Dystonia]],<ref>{{Cite journal|author=Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM |title=Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |journal=Movement Disorders |volume=17 |issue=1 |pages=145–9 |year=2002 |month=January |pmid=11835452 |doi=10.1002/mds.1280 |issn=0885-3185}}</ref> [[Epilepsy]],<ref>{{cite web|url=http://www.telegraph.co.uk/science/science-news/8440303/Cannabis-could-be-used-to-treat-epilepsy.html |title=Cannabis could be used to treat epilepsy |publisher=Telegraph |date=2011-04-10 |accessdate=2011-04-20}}</ref><ref>{{Cite journal|author=Marsicano G, Goodenough S, Monory K, ''et al.'' |title=CB1 cannabinoid receptors and on-demand defense against excitotoxicity |journal=Science |volume=302 |issue=5642 |pages=84–8 |year=2003 |month=October |pmid=14526074 |doi=10.1126/science.1088208 |last12=Casanova |first12=E |last13=Schütz |first13=G |last14=Zieglgänsberger |first14=W |last15=Di Marzo |first15=V |last16=Behl |first16=C |last17=Lutz |first17=B |issn=0036-8075}}</ref><ref>{{Cite journal|author=Bacci A, Huguenard JR, Prince DA |title=Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids |journal=Nature |volume=431 |issue=7006 |pages=312–6 |year=2004 |month=September |pmid=15372034 |doi=10.1038/nature02913 |laysummary=http://www.sciencedaily.com/releases/2004/09/040916102315.htm |laysource=[[Science Daily]] |laydate=16 September 2004 |issn=0028-0836}}</ref> [[Hepatitis C]],<ref>{{Cite journal|author=Sylvestre DL, Clements BJ, Malibu Y |title=Cannabis use improves retention and virological outcomes in patients treated for hepatitis C |journal=European Journal of Gastroenterology & Hepatology |volume=18 |issue=10 |pages=1057–63 |year=2006 |month=October |pmid=16957511 |doi=10.1097/01.meg.0000216934.22114.51 |issn=0954-691X}}</ref> [[Depression]],<ref>{{Cite journal|author=Bambico FR, Katz N, Debonnel G, Gobbi G |title=Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex |journal=The Journal of Neuroscience |volume=27 |issue=43 |pages=11700–11 |year=2007 |month=October |pmid=17959812 |doi=10.1523/JNEUROSCI.1636-07.2007 |laysummary=http://www.foxnews.com/story/0,2933,304996,00.html |laysource=[[Fox News Channel]] |laydate=25 October 2007 |issn=0270-6474 |url=http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=17959812 |format=Free full text}}</ref><ref>{{Cite journal|author=Denson TF, Earleywine M |title=Decreased depression in marijuana users |journal=Addictive Behaviors |volume=31 |issue=4 |pages=738–42 |year=2006 |month=April |pmid=15964704 |doi=10.1016/j.addbeh.2005.05.052 |url=http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/DecreasedDepressionInMjUsers05.pdf |issn=0306-4603}}</ref><ref name="Zhang_etal">{{Cite journal|author=Jiang W, Zhang Y, Xiao L, ''et al.'' |title=Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects |journal=The Journal of Clinical Investigation |volume=115 |issue=11 |pages=3104–16 |year=2005 |month=November |pmid=16224541 |pmc=1253627 |doi=10.1172/JCI25509 |issn=0021-9738 |format=Free full text}}</ref><ref>{{Cite journal|author=El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI |title=Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes |journal=The American Journal of Pathology |volume=168 |issue=1 |pages=235–44 |year=2006 |month=January |pmid=16400026 |pmc=1592672 |doi=10.2353/ajpath.2006.050500 |issn=0002-9440 |url=http://ajp.amjpathol.org/cgi/pmidlookup?view=long&pmid=16400026 |format=Free full text}}</ref> [[Leukemia]],<ref>{{Cite journal|author=Powles T, te Poele R, Shamash J, ''et al.'' |title=Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway |journal=Blood |volume=105 |issue=3 |pages=1214–21 |year=2005 |month=February |pmid=15454482 |doi=10.1182/blood-2004-03-1182 |issn=0006-4971 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=15454482 |format=Free full text}}</ref> [[Huntington's Disease]],<ref>{{cite web|url=http://www.druglibrary.org/schaffer/hemp/medical/cannabid.htm |title=Cannabidiol: The Wonder Drug of the 21st Century? |publisher=Schaffer Library of Drug Policy |date= |accessdate=10 August 2009}}{{Verify credibility|date=August 2009}}</ref> [[Parkinson's Disease]],<ref>{{Cite journal|author=Kreitzer AC, Malenka RC |title=Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models |journal=Nature |volume=445 |issue=7128 |pages=643–7 |year=2005 |month=February |pmid=17287809 |doi=10.1038/nature05506 |laysummary=http://med.stanford.edu/news_releases/2007/february/malenka.html |laysource=[[Stanford University School of Medicine]] |laydate=7 February 2007 |issn=0028-0836}}</ref> [[Pruritus]],<ref>{{Cite journal|author=Szepietowski JC, Szepietowski T, Reich A |title=Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study |journal=Acta Dermatovenerologica Croatica |volume=13 |issue=2 |pages=97–103 |year=2005 |pmid=16324422 |issn=1330-027X}}</ref><ref>{{Cite journal|author=Bergasa NV |title=The pruritus of cholestasis |journal=Journal of Hepatology |volume=43 |issue=6 |pages=1078–88 |year=2005 |month=December |pmid=16253381 |doi=10.1016/j.jhep.2005.09.004 |issn=0168-8278}}</ref> [[Methicillin-Resistant Staphylococcus Aureus (MRSA)]],<ref>{{Cite journal|author=Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, Smith E, Rahman MM |title=Antibacterial Cannabinoids from ''Cannabis sativa'': A Structure—Activity Study |journal=J Nat Prod |volume=71 |issue=8 |pages=1427–30 |year=2008|pmid=18681481 |doi=10.1021/np8002673 |url=http://pubs.acs.org/doi/pdf/10.1021/np8002673 |format=PDF |laysummary=http://www.webmd.com/news/20080904/marijuana-chemicals-may-fight-mrsa |laysource=[[WebMD]] |laydate=4 September 2008 |accessdate=6 November 2010}}</ref> [[Sickle-Cell Disease]],<ref>{{cite web|url=http://www.ncbi.nlm.nih.gov/pubmed/16173972 |title=Cannabis use in sickle cell disease: A questionnaire study |date= |accessdate=9 June 2010}}</ref> [[Posttraumatic Stress Disorder (PTSD)]],<ref>{{Cite journal|url=http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=123#1 |title=Science: Endocannabinoids extinguish bad memories in the brain |publisher=International Association for Cannabis as Medicine |journal=IACM-Bulletin |date=4 August 2002 |accessdate=11 August 2009}}</ref> [[Sleep Apnea]],<ref>{{Cite journal|author=Carley DW, Paviovic S, Janelidze M, Radulovacki M |title=Functional role for cannabinoids in respiratory stability during sleep |journal=Sleep |volume=25 |issue=4 |pages=391–8 |year=2002 |month=June |pmid=12071539 |issn=0161-8105 |url=http://www.scholaruniverse.com/ncbi-linkout?id=12071539 |format=Free full text}}</ref> and [[Artherosclerosis]]<ref>{{Cite journal|title=Cannabis may help keep arteries clear |date=16 April 2005 |doi=10.1038/nature03389 |journal=New Scientist |author=Steffens, Sabine |volume=434 |page=782 |pmid=15815632 |last1=Steffens |first1=S |last2=Veillard |first2=NR |last3=Arnaud |first3=C |last4=Pelli |first4=G |last5=Burger |first5=F |last6=Staub |first6=C |last7=Karsak |first7=M |last8=Zimmer |first8=A |last9=Frossard |first9=JL |issue=7034 |issn=0028-0836}}</ref>). | + | '''"Medical" marijuana''' is [[marijuana]] used for its claimed analgesic or otherwise therapeutic effects (see [[Glaucoma]], [[Cancer]],<ref>{{Cite journal|author=Casanova ML, Blázquez C, Martínez-Palacio J, ''et al.'' |title=Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |journal=The Journal of Clinical Investigation |volume=111 |issue=1 |pages=43–50 |year=2003 |month=January |pmid=12511587 |pmc=151833 |doi=10.1172/JCI16116 |issn=0021-9738 |format=Free full text}}</ref><ref>{{Cite journal|author=Patsos HA, Hicks DJ, Dobson RR, ''et al.'' |title=The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 |journal=Gut |volume=54 |issue=12 |pages=1741–50 |year=2005 |month=December |pmid=16099783 |pmc=1774787 |doi=10.1136/gut.2005.073403 |issn=0017-5749}}</ref><ref>{{Cite journal|author=Lorente M, Carracedo A, Torres S, ''et al.'' |title=Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis |journal=Glia |volume= 57|issue= 13|pages=NA |year=2009 |month=February |pmid=19229996 |doi=10.1002/glia.20856 |issn=0894-1491}}</ref><ref>{{Cite journal|author=Ramer R, Hinz B |title=Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 |journal=Journal of the National Cancer Institute |volume=100 |issue=1 |pages=59–69 |year=2008 |month=January |pmid=18159069 |doi=10.1093/jnci/djm268 |issn=0027-8874 |url=http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18159069 |format=Free full text}}</ref><ref>{{Cite journal|author=Powles T, te Poele R, Shamash J, ''et al.'' |title=Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway |journal=Blood |volume=105 |issue=3 |pages=1214–21 |year=2005 |month=February |pmid=15454482 |doi=10.1182/blood-2004-03-1182 |issn=0006-4971 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=15454482 |format=Free full text}}</ref> [[Anorexia Nervosa]],<ref>Grotenhermen, Russo. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential . New York: The Hawthorn Integrative Healing Press, 2002,. Grotenhermen, “Review of Therapeutic Effects.” Chapter 11, p. 128</ref> [[Amyotrophic Lateral Sclerosis]],<ref>{{Cite journal|author=Carter GT, Rosen BS |title=Marijuana in the management of amyotrophic lateral sclerosis |journal=The American Journal of Hospice & Palliative Care |volume=18 |issue=4 |pages=264–70 |year=2001 |pmid=11467101 |doi=10.1177/104990910101800411 |month= July|issn=1049-9091}}</ref><ref>{{Cite journal|author=Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M |title=Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival |journal=Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders |volume=6 |issue=3 |pages=182–4 |year=2005 |month=September |pmid=16183560 |doi=10.1080/14660820510030149 |url=http://www.informaworld.com/smpp/content~db=all~content=a723777607 |issn=1466-0822}}</ref> [[Seizures]], [[Schizophrenia]],<ref>Zuardi A.W., Crippa J.A.S., Hallak J.E.C., Moreira F.A., Guimarães F.S. Brazilian Journal of Medical and Biological Research [http://www.scielo.br/pdf/bjmbr/v39n4/6164.pdf Cannabidiol as an antipsychotic drug] (PDF) 2006. Vol. 39. Page 421-9. ISSN 0100-879X</ref> [[tumor|Skin Tumors]],<ref>{{Cite journal|author=Casanova ML, Blázquez C, Martínez-Palacio J, ''et al.'' |title=Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |journal=The Journal of Clinical Investigation |volume=111 |issue=1 |pages=43–50 |year=2003 |month=January |pmid=12511587 |pmc=151833 |doi=10.1172/JCI16116 |issn=0021-9738 |format=Free full text}}</ref><ref>[http://www.sciencedaily.com/releases/2007/04/070417193338.htm Science Daily 4/7/2007]</ref> [[Gliomas]],<ref>{{Cite journal|author=Lorente M, Carracedo A, Torres S, ''et al.'' |title=Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis |journal=Glia |volume= 57|issue= 13|pages=NA |year=2009 |month=February |pmid=19229996 |doi=10.1002/glia.20856 |issn=0894-1491}}</ref><ref>{{Cite journal|author=Ramer R, Hinz B |title=Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 |journal=Journal of the National Cancer Institute |volume=100 |issue=1 |pages=59–69 |year=2008 |month=January |pmid=18159069 |doi=10.1093/jnci/djm268 |issn=0027-8874 |url=http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18159069 |format=Free full text}}</ref> [[Arthritis]],<ref>{{Cite journal|author=Malfait AM, Gallily R, Sumariwalla PF, ''et al.'' |title=The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis |journal=Proceedings of the National Academy of Sciences of the United States of America |volume=97 |issue=17 |pages=9561–6 |year=2000 |month=August |pmid=10920191 |pmc=16904 |doi=10.1073/pnas.160105897 |issn=0027-8424 |url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=10920191 |format=Free full text}}</ref> [[Bipolar Disorder]],<ref>{{Cite journal|author=Grinspoon L, Bakalar JB |title=The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research |journal=Journal of Psychoactive Drugs |volume=30 |issue=2 |pages=171–7 |year=1998 |pmid=9692379 |url=http://www.ukcia.org/research/TheUseofCannabisasaMoodStabilizerinBipolarDisorder.html |month= April|issn=0279-1072}}</ref><ref>{{Cite journal|author=Ashton CH, Moore PB, Gallagher P, Young AH |title=Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential |journal=Journal of Psychopharmacology |volume=19 |issue=3 |pages=293–300 |year=2005 |month=May |pmid=15888515 |doi=10.1177/0269881105051541 |issn=0269-8811}}</ref> [[Dystonia]],<ref>{{Cite journal|author=Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM |title=Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |journal=Movement Disorders |volume=17 |issue=1 |pages=145–9 |year=2002 |month=January |pmid=11835452 |doi=10.1002/mds.1280 |issn=0885-3185}}</ref> [[Epilepsy]],<ref>{{cite web|url=http://www.telegraph.co.uk/science/science-news/8440303/Cannabis-could-be-used-to-treat-epilepsy.html |title=Cannabis could be used to treat epilepsy |publisher=Telegraph |date=2011-04-10 |accessdate=2011-04-20}}</ref><ref>{{Cite journal|author=Marsicano G, Goodenough S, Monory K, ''et al.'' |title=CB1 cannabinoid receptors and on-demand defense against excitotoxicity |journal=Science |volume=302 |issue=5642 |pages=84–8 |year=2003 |month=October |pmid=14526074 |doi=10.1126/science.1088208 |last12=Casanova |first12=E |last13=Schütz |first13=G |last14=Zieglgänsberger |first14=W |last15=Di Marzo |first15=V |last16=Behl |first16=C |last17=Lutz |first17=B |issn=0036-8075}}</ref><ref>{{Cite journal|author=Bacci A, Huguenard JR, Prince DA |title=Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids |journal=Nature |volume=431 |issue=7006 |pages=312–6 |year=2004 |month=September |pmid=15372034 |doi=10.1038/nature02913 |laysummary=http://www.sciencedaily.com/releases/2004/09/040916102315.htm |laysource=[[Science Daily]] |laydate=16 September 2004 |issn=0028-0836}}</ref> [[Hepatitis C]],<ref>{{Cite journal|author=Sylvestre DL, Clements BJ, Malibu Y |title=Cannabis use improves retention and virological outcomes in patients treated for hepatitis C |journal=European Journal of Gastroenterology & Hepatology |volume=18 |issue=10 |pages=1057–63 |year=2006 |month=October |pmid=16957511 |doi=10.1097/01.meg.0000216934.22114.51 |issn=0954-691X}}</ref> [[Depression]],<ref>{{Cite journal|author=Bambico FR, Katz N, Debonnel G, Gobbi G |title=Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex |journal=The Journal of Neuroscience |volume=27 |issue=43 |pages=11700–11 |year=2007 |month=October |pmid=17959812 |doi=10.1523/JNEUROSCI.1636-07.2007 |laysummary=http://www.foxnews.com/story/0,2933,304996,00.html |laysource=[[Fox News Channel]] |laydate=25 October 2007 |issn=0270-6474 |url=http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=17959812 |format=Free full text}}</ref><ref>{{Cite journal|author=Denson TF, Earleywine M |title=Decreased depression in marijuana users |journal=Addictive Behaviors |volume=31 |issue=4 |pages=738–42 |year=2006 |month=April |pmid=15964704 |doi=10.1016/j.addbeh.2005.05.052 |url=http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/DecreasedDepressionInMjUsers05.pdf |issn=0306-4603}}</ref><ref name="Zhang_etal">{{Cite journal|author=Jiang W, Zhang Y, Xiao L, ''et al.'' |title=Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects |journal=The Journal of Clinical Investigation |volume=115 |issue=11 |pages=3104–16 |year=2005 |month=November |pmid=16224541 |pmc=1253627 |doi=10.1172/JCI25509 |issn=0021-9738 |format=Free full text}}</ref><ref>{{Cite journal|author=El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI |title=Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes |journal=The American Journal of Pathology |volume=168 |issue=1 |pages=235–44 |year=2006 |month=January |pmid=16400026 |pmc=1592672 |doi=10.2353/ajpath.2006.050500 |issn=0002-9440 |url=http://ajp.amjpathol.org/cgi/pmidlookup?view=long&pmid=16400026 |format=Free full text}}</ref> [[Leukemia]],<ref>{{Cite journal|author=Powles T, te Poele R, Shamash J, ''et al.'' |title=Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway |journal=Blood |volume=105 |issue=3 |pages=1214–21 |year=2005 |month=February |pmid=15454482 |doi=10.1182/blood-2004-03-1182 |issn=0006-4971 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=15454482 |format=Free full text}}</ref> [[Huntington's Disease]],<ref>{{cite web|url=http://www.druglibrary.org/schaffer/hemp/medical/cannabid.htm |title=Cannabidiol: The Wonder Drug of the 21st Century? |publisher=Schaffer Library of Drug Policy |date= |accessdate=10 August 2009}}{{Verify credibility|date=August 2009}}</ref> [[Parkinson's Disease]],<ref>{{Cite journal|author=Kreitzer AC, Malenka RC |title=Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models |journal=Nature |volume=445 |issue=7128 |pages=643–7 |year=2005 |month=February |pmid=17287809 |doi=10.1038/nature05506 |laysummary=http://med.stanford.edu/news_releases/2007/february/malenka.html |laysource=[[Stanford University School of Medicine]] |laydate=7 February 2007 |issn=0028-0836}}</ref> [[Pruritus]],<ref>{{Cite journal|author=Szepietowski JC, Szepietowski T, Reich A |title=Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study |journal=Acta Dermatovenerologica Croatica |volume=13 |issue=2 |pages=97–103 |year=2005 |pmid=16324422 |issn=1330-027X}}</ref><ref>{{Cite journal|author=Bergasa NV |title=The pruritus of cholestasis |journal=Journal of Hepatology |volume=43 |issue=6 |pages=1078–88 |year=2005 |month=December |pmid=16253381 |doi=10.1016/j.jhep.2005.09.004 |issn=0168-8278}}</ref> [[Methicillin-Resistant Staphylococcus Aureus (MRSA)]],<ref>{{Cite journal|author=Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, Smith E, Rahman MM |title=Antibacterial Cannabinoids from ''Cannabis sativa'': A Structure—Activity Study |journal=J Nat Prod |volume=71 |issue=8 |pages=1427–30 |year=2008|pmid=18681481 |doi=10.1021/np8002673 |url=http://pubs.acs.org/doi/pdf/10.1021/np8002673 |format=PDF |laysummary=http://www.webmd.com/news/20080904/marijuana-chemicals-may-fight-mrsa |laysource=[[WebMD]] |laydate=4 September 2008 |accessdate=6 November 2010}}</ref> [[Sickle-Cell Disease]],<ref>{{cite web|url=http://www.ncbi.nlm.nih.gov/pubmed/16173972 |title=Cannabis use in sickle cell disease: A questionnaire study |date= |accessdate=9 June 2010}}</ref> [[Posttraumatic Stress Disorder (PTSD)]],<ref>{{Cite journal|url=http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=123#1 |title=Science: Endocannabinoids extinguish bad memories in the brain |publisher=International Association for Cannabis as Medicine |journal=IACM-Bulletin |date=4 August 2002 |accessdate=11 August 2009}}</ref> [[Sleep Apnea]],<ref>{{Cite journal|author=Carley DW, Paviovic S, Janelidze M, Radulovacki M |title=Functional role for cannabinoids in respiratory stability during sleep |journal=Sleep |volume=25 |issue=4 |pages=391–8 |year=2002 |month=June |pmid=12071539 |issn=0161-8105 |url=http://www.scholaruniverse.com/ncbi-linkout?id=12071539 |format=Free full text}}</ref> and [[Artherosclerosis]]<ref>{{Cite journal|title=Cannabis may help keep arteries clear |date=16 April 2005 |doi=10.1038/nature03389 |journal=New Scientist |author=Steffens, Sabine |volume=434 |page=782 |pmid=15815632 |last1=Steffens |first1=S |last2=Veillard |first2=NR |last3=Arnaud |first3=C |last4=Pelli |first4=G |last5=Burger |first5=F |last6=Staub |first6=C |last7=Karsak |first7=M |last8=Zimmer |first8=A |last9=Frossard |first9=JL |issue=7034 |issn=0028-0836}}</ref>). |